CEPE Phase II Prototype Unit
CEPE Phase III Industrial Unit
Meet the real CEPE®II the only one of its kind solvent free botanical extractor / processor Centrifugal Electrostatic Precipitator Extraction “unit”. Our patented technology has been in development for about three years now and CEPE®II represents the developed unit, which is a miniature version of our 200 Kg per day industrial scale unit presently in the design and procurement stage and pictured here. The CEPE® process extracts botanical compounds without the use of solvents and directly infuses the compounds into one of several possible carrier fluids resulting in finished products directly from the CEPE® machine. The same machine can also output the extraction as a high purity broad spectrum oil. The carrier fluid never comes into contact with the botanical feedstock material. The CEPE III industrial unit is targeted to process 200 Kg of Biomass per day.
CEPE® eliminates the use of solvents, bypasses 4 of the 5 traditional processes in solvent extractions and directly produces infused liquid products and/or high purity oil products.
Compare our Technology to Industry Standards here:
Existing methods of extracting compounds from botanical materials, particularly cannabis botanical materials, primarily rely on the use of a solvent of some form to directly treat or soak the botanical materials in a way that releases all or most of the available soluble compounds in the plant material into the solvent, leaving only the non-soluble parts of the plant behind (which are discarded).
Once the solvent used has been drained and then evaporated off, both desired and un-desired compounds dissolved out of the plant material remain behind as a complex mixture of compounds forming a viscous sap or tar like substance, which is often called Crude and includes compounds such as CBDA, THCA and many other compounds as well as possibly chemical fungicides, insecticides and potentially fertilizers and other trace chemicals or heavy metals (from the soils used to grow the original botanical material).
Post processing of the Crude using winterization, evaporation and distillation (a temperature related condensation process) is used to separate and isolate the desired compounds from the un-desired or un-used compounds and also to convert the CBDA and THCA via decarboxylation to the more desired compounds CBD and THC.
This overall process in one form or another is how existing botanical extraction technology works, and always uses some form of solvent in the process.
The CEPE process does not use any solvents in the process. Instead, the compounds normally evaporated after the solvents have been evaporated in the existing process, are evaporated directly from the botanical material while it is in the botanical material form, using an inert, temperature controlled sweeper gas.
The temperature of the sweeper gas determines which compound will be evaporated from the botanical material, and as such the lowest vapor temperature compound is collected first, followed by the next higher vapor temperature compound in a process which is akin to the distillation process used in the existing process following solvent removal, however, no solvents are used in the CEPE process.
The vapor at any specific temperature (contains mostly the specific compound having that vaporization temperature) is passed into the CEPE (Centrifugal Electrostatic Precipitator) section, where this unique invention converts the vapor back into a liquid state for collection.
In the latest configuration of the CEPE prototype (Phase II CEPE, May 2021) we have demonstrated conversion of the vapour back into Nanoparticle droplets and direct injection of these nanoparticles into a number of different carrier fluids), which include direct injection into VG (Vegetable Glycerine) and MCT oil (Medium-Chain Triglycerides oil). We have also now demonstrated direct production of high purity broad spectrum distillate oils.
These improved capabilities allow production of botanical concentrates directly from the CEPE process still without the use of solvents. The botanical material never comes into contact with the carrier fluid or the produced oils.
The VG product can be used as an e-fluid for vaping and is miscible in water based drinks for direct consumption as a beverage.
It could also be used as an additive to make edibles and can also be used directly as a tincture.
VG is also often used as an ointment directly applied to the skin as well.
MCT oil is often used in medicinal applications as a carrier for CBD, and can be produced directly using the Phase II CEPE.
Each compound is evaporated and collected from the botanical material in this way in a sequentially increasing temperature process.
At temperatures where toxins or un-desirable compounds are known to exist, the vapor is not collected and converted but is instead filtered and exhausted out of the system.
The content of this website is owned by KADI Botanical Inc. ("KADI") and is protected by copyright law, as a collective work and compilation, both in Canada and abroad.
This website is designed for information purposes only. KADI has taken all reasonable care in producing and publishing the information contained in this website. The information is taken from sources believed to be reliable, and the information is believed to be accurate at the time it is posted to the website. However, there is no way to ensure that the information is accurate at any particular moment in time. Material on the site may still contain technical or other inaccuracies, omissions, or typographical errors, for which KADI assumes no responsibility. KADI does not warrant or make any representations regarding the use, accuracy, completeness, reliability or validity of any claims, statements or information on this site.
The information is not designed to provide financial, tax planning, accounting, investment, business or legal advice, in any way whatsoever. Furthermore, the information in no way should be construed or interpreted as, or as a part of, an offering or solicitation of securities. Investors are advised to discuss any trading with a registered securities broker or personal finance professional prior to investing.
KADI and its officers, directors, subsidiaries, affiliates, contractors, agents, employees, licensors, and/or third-party content providers are in no way responsible or liable for any damages whether they be direct, indirect, consequential, incidental, special, punitive, exemplary or general damages, contribution or indemnity, of any kind whatsoever, however caused, including loss of profits, in connection with, caused by or arising from the use or non-availability of this website, or reliance on the information contained herein, the links to other sites as contained in this website or any information on such sites, or any delays, inaccuracies, errors or omissions in the information contained on this site. This limitation of liability shall hold even if KADI, its subsidiaries, affiliates, contractors, agents, employees, licensors, and/or third party content providers were warned of the possibility of damages referred in this disclaimer.
No securities commission or other regulatory authority in Canada or any other country or jurisdiction has in any way reviewed or approved this information and no representation or warranty is made by KADI to that effect. KADI is not responsible for the content of sites that can be reached through links on this site.
Forward-looking Statements
Information set forth on this website may contain forward-looking statements. Forward-looking statements are statements that relate to the future, not past events. In this context, forward-looking statements often address a company’s expected future business and financial performance, and often contains words such as “anticipate”, “believe”, “plan”, “estimate”, “expect” and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievement expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: risks associated with project development; the need for additional financing; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and KADI undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements.
KADI reserves the right to modify this disclaimer without prior notice by posting modifications to this website.